
Choose from 5 options:
Produce evaluations that are targeted and evidence-based through effective use of data
We need a range of information to produce robust evaluations including data on hazard characteristics and potential exposure to humans and the environment.
We draw on a range of publicly available sources, including:
We confirm the scientific integrity of information before using it to:
Where possible, we will ‘group’ chemicals using scientific and technical guidance. This will promote efficiency and consistent decision making on similar chemicals based on:
We use conservative assumptions based on a technical rationale and scientific principles so that we do not underestimate the risks to human health or the environment. We inform ‘data poor’ evaluations through inferring properties and use patterns of chemicals using data for similar substances or international practices.
With the lack of specific Australian exposure data and the global move away from the use of traditional animal toxicity data, we use relevant information to inform the following assumptions will help us do an evaluation:
If available international or national data are not enough to estimate volumes, we assume an annual introduction volume of 100 tonnes. Doing this assists us to estimate the magnitude of human and/or environmental exposure. We established this assumption after consultation with stakeholders. It is typically greater than actual introduction volumes and results in a conservative estimation of the risk posed by the chemical.
Where we need to rely on results from QSAR modelling and read-across methods for an evaluation, we scale them to account for the degree of uncertainty. This also provides a conservative estimate of actual hazard and risk to ensure risk management recommendations that protect human health and the environment.
We make every effort to obtain use and volume estimates. Australian use and exposure information will not be readily available for most chemicals listed on the Inventory. International data are a vital source of surrogate exposure information for these industrial chemicals. Where data are not readily available and is required to complete an evaluation we may seek information from stakeholders. Provision by regulated entities (or other sources) of more accurate data on uses and volumes will allow refinement of risk estimates.
Introducers and other interested parties have several opportunities to provide input to the evaluation process, including by:
We prioritise any nominations with other potential candidates for evaluation. Nominations would need to include key information on the hazards and potential for human health or environmental exposure to the industrial chemical so we can decide on the appropriate priority.
We will keep stakeholders informed about the chemicals we will evaluate through:
This early communication will allow interested parties to voluntarily give us information and help with stakeholder preparedness.
As well as publishing lists of chemicals for evaluation, we may also do targeted voluntary calls for information.
Read more in 'What happens during an evaluation'
Often we can evaluate a chemical with information we have on hand or that we have received through consultation. When we publish or update our Rolling Action Plan, there will be opportunity for stakeholders to give information voluntarily. Sometimes, we may need to make it a requirement that they provide information.
We can issue a call for information during an evaluation, for example to a specific introducer or industry sector. However, anyone can provide us with information at any time about a chemical. Anyone giving information to us may flag information as confidential.
Learn about circumstances when AICIS can call for information
We can consult with risk management bodies at any time during an evaluation. In particular circumstances, we must consult with specific standard-setting bodies and/or state and territory risk-management agencies (prescribed bodies).